Literature DB >> 22542368

[Keloid scars on black skin: myth or reality].

K C Allah1, S Yéo, H Kossoko, V Assi Djè Bi Djè, M Richard Kadio.   

Abstract

UNLABELLED: The keloid scar is a thick skin or the cornea of man, due to excessive accumulation of type I collagen in the dermis. Morbidity of the keloid is high, given the frequent recurrences and unpredictable. African blacks and Asians are most affected. The purpose of this study was to analyze the results of treatment of 149 cases of keloids and discuss the reality of keloids in the dark. PATIENTS AND METHODS: From 1990 to 2011, 98 patients were supported for 149 keloid tumors.
RESULTS: Seventy-eight adults (79.6%) and 20 children (20.4%) were received. Sixty-four women (65.3%) and 34 men (34.7%) were supported, including 94 blacks (96%) and four redheads (4%). The average age was 25 years with extremes of 2 years and 54 years. The trauma was the dominant etiology in 63.1% of cases. The infection, burns and surgery were implicated in 16.8%, respectively, 15% and 4.7% of cases. The cephalic end, was the seat of choice for keloids, with 84 cases or 56.4%. The ear has been the preferred unit in 38 cases, or 25.5%. The body, legs and genital area were the site of keloids, respectively, in 22.8%, 17.5%) and 3.3% of cases. Keloidal field was found in 24.5% of our cases. The reasons for consultation were the disgrace aesthetics (56.4%), pain (65%), households suppurative intrakeloidal (44.9%), functional impairment (40.8%), and the psychological impact minor (15.3%) and no major suicide attempt (66.3%). Two surgical techniques were used: total excision (TE), with total skin graft immediate or deferred, or not expanded, and intrakeloid excision (IKE) with suture surgery was associated with intra-lesional steroids. Many complications have favored the occurrence of early or late recurrence in 100% of our cases.
CONCLUSION: The keloid is not a homogenous biological entity. Its prevalence is higher among black and yellow, and lowest among whites. The research results are still being evaluated. The best prevention is to avoid the scar itself.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542368     DOI: 10.1016/j.anplas.2012.02.005

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  6 in total

1.  An intra-individual surgical wound comparison shows that octenidine-based hydrogel wound dressing ameliorates scar appearance following abdominoplasty.

Authors:  Johannes Matiasek; Philip Kienzl; Lukas W Unger; Christoph Grill; Rupert Koller; Bela R Turk
Journal:  Int Wound J       Date:  2018-06-29       Impact factor: 3.315

2.  Predisposing factors for adverse skin reactions with percutaneous bone anchored hearing devices implanted with skin reduction techniques.

Authors:  Claudia Candreia; Ruth Birrer; Susanna Fistarol; Martin Kompis; Marco Caversaccio; Andreas Arnold; Christof Stieger
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-01       Impact factor: 2.503

3.  Functional analysis of keratinocyte and fibroblast gene expression in skin and keloid scar tissue based on deviation analysis of dynamic capabilities.

Authors:  Mingming Li; Lei Wu
Journal:  Exp Ther Med       Date:  2016-10-18       Impact factor: 2.447

4.  Clitoral keloids after female genital mutilation/cutting.

Authors:  Özer Birge; Murat Akbaş; Ertuğrul Gazi Özbey; Mehmet Adıyeke
Journal:  Turk J Obstet Gynecol       Date:  2016-09-15

5.  MicroRNA-21 may be involved in the therapeutic effects of Galla chinensis ointment on keloid.

Authors:  Zhiming Tang; Jicun Ding; Xiaoxiang Zhai; Mengqing Jing; Zhiqiang Guan; Yongcong Li
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

6.  Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1β, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids.

Authors:  Yan Hao; Xinhang Dong; Mingzi Zhang; Hao Liu; Lin Zhu; Youbin Wang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.